Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial
PaperCitations, authors & open-access status
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 220 citations, 2016 year and closed oa status.
220
Citations
2016
Year
closed
OA Status